Product Information
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.4620 per EA under NDC 16729054910. Its NADAC has been published 288 times since Feb 17, 2021.
FDA first approved this application on Jul 17, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATEStrength
2; .5 mg/1; mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729054910
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209069FDA Approved
7/17/2020
TE Code
AB
On Market Since
9/1/2020
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has been published 288 times since Feb 17, 2021, and over the history we have for it it has declined 51.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4620 per EA |
|---|---|
| All-time high | $1.0654 (Aug 11, 2021) |
| All-time low | $0.3740 (Nov 20, 2024) |
| 52-week high | $0.5463 |
| 52-week low | $0.4123 |
| Median price | $0.5915 |
| Average price | $0.6278 |
| Largest weekly change | +58.5% (Aug 21, 2024) |
| Weeks tracked | 288 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET, manufactured by Accord Healthcare Inc., is $0.4620 per EA (NDC 16729054910), effective Aug 19, 2026.
How has the price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has declined 51.4%. It has been tracked across 288 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
Since Feb 17, 2021, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has ranged from a low of $0.3740 (Nov 20, 2024) to a high of $1.0654 (Aug 11, 2021), with a median of $0.5915 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET (NDC 16729054910) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.